CC BY-NC-ND 4.0 · Endosc Int Open 2024; 12(03): E435-E439
DOI: 10.1055/a-2271-2411
Innovation forum

Gel immersion endoscopic mucosal resection for early gastric neoplasms: a multicenter case series study

1   Division of Digestive Endoscopy, Shiga University of Medical Science, Otsu, Japan (Ringgold ID: RIN13051)
,
Yoichi Yamamoto
2   Division of Endoscopy, Shizuoka Cancer Center, Sunto-gun, Japan (Ringgold ID: RIN38471)
,
Yohei Yabuuchi
3   Department of Gastroenterology, Kobe City Medical Center General Hospital, Kobe, Japan (Ringgold ID: RIN26330)
,
Kohei Shigeta
2   Division of Endoscopy, Shizuoka Cancer Center, Sunto-gun, Japan (Ringgold ID: RIN38471)
,
2   Division of Endoscopy, Shizuoka Cancer Center, Sunto-gun, Japan (Ringgold ID: RIN38471)
,
Soichiro Nagao
3   Department of Gastroenterology, Kobe City Medical Center General Hospital, Kobe, Japan (Ringgold ID: RIN26330)
,
Akito Noguchi
4   Division of Gastroenterology, Shiga University of Medical Science, Otsu, Japan (Ringgold ID: RIN13051)
,
Yukihiro Morita
4   Division of Gastroenterology, Shiga University of Medical Science, Otsu, Japan (Ringgold ID: RIN13051)
,
Shuhei Shintani
4   Division of Gastroenterology, Shiga University of Medical Science, Otsu, Japan (Ringgold ID: RIN13051)
,
Osamu Inatomi
4   Division of Gastroenterology, Shiga University of Medical Science, Otsu, Japan (Ringgold ID: RIN13051)
,
Hiroyuki Ono
2   Division of Endoscopy, Shizuoka Cancer Center, Sunto-gun, Japan (Ringgold ID: RIN38471)
,
Akira Andoh
4   Division of Gastroenterology, Shiga University of Medical Science, Otsu, Japan (Ringgold ID: RIN13051)
› Author Affiliations

Abstract

Several cases have been reported that suggest the efficacy of gel immersion endoscopic mucosal resection (GI-EMR) for gastric neoplasms. However, no study has evaluated treatment outcomes of GI-EMR for gastric neoplasms. This study aimed to investigate the efficacy and safety of GI-EMR for early gastric neoplasms. Nine patients (17 lesions) undergoing gastric GI-EMR were included, with a median lesion size of 10 mm (interquartile range [IQR] 5–13 mm). All lesions were protruding or flat elevated. The median procedure time was 3 minutes (IQR 2–5) and en bloc resection was achieved in all cases. Among 15 neoplastic lesions, the R0 resection rate was 86.7% (13/15 lesions). Adverse events included immediate bleeding requiring hemostasis in two cases, which was controlled endoscopically. No delayed bleeding or perforation occurred. In conclusion, GI-EMR may be a safe and effective treatment for early, small gastric neoplasms. However, due to the small sample in the present study, further investigation is required regarding the indication for this technique.



Publication History

Received: 25 November 2023

Accepted after revision: 15 February 2024

Accepted Manuscript online:
19 February 2024

Article published online:
18 March 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany